Victory Capital Management
EBS icon

Victory Capital Management’s Emergent Biosolutions EBS Stock Holding History

Victory Capital Management’s Portfolio EBS Stock Details EBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-70,837
Closed -$734K – 2542
2023
Q1 		$734K Sell
70,837
-97,231
-58% -$1.18M ﹤0.01% 1849
2022
Q4 		$1.98M Buy
168,068
+105,439
+168% +$1.63M ﹤0.01% 1442
2022
Q3 		$1.31M Buy
62,629
+27,456
+78% +$764K ﹤0.01% 1612
2022
Q2 		$1.09M Buy
35,173
+2,525
+8% +$86.2K ﹤0.01% 1699
2022
Q1 		$1.06M Buy
32,648
+11,152
+52% +$492K ﹤0.01% 1787
2021
Q4 		$934K Buy
21,496
+657
+3% +$29.7K ﹤0.01% 1873
2021
Q3 		$1.04M Buy
20,839
+658
+3% +$39.8K ﹤0.01% 1844
2021
Q2 		$1.27M Sell
20,181
-24,910
-55% -$1.6M ﹤0.01% 1807
2021
Q1 		$4.19M Buy
45,091
+30,787
+215% +$3.15M ﹤0.01% 1403
2020
Q4 		$1.28M Sell
14,304
-23,302
-62% -$2.14M ﹤0.01% 1675
2020
Q3 		$3.89M Sell
37,606
-2,891
-7% -$312K 0.01% 1251
2020
Q2 		$3.2M Buy
40,497
+26,265
+185% +$1.96M ﹤0.01% 1286
2020
Q1 		$824K Buy
14,232
+1,635
+13% +$94.2K ﹤0.01% 1920
2019
Q4 		$680K Sell
12,597
-181
-1% -$9.82K ﹤0.01% 1877
2019
Q3 		$668K Buy
+12,778
New +$595K ﹤0.01% 1798
2018
Q3 		– Sell
-5,809
Closed -$293K – 1816
2018
Q2 		$293K Buy
5,809
+798
+16% +$41.6K ﹤0.01% 1539
2018
Q1 		$264K Sell
5,011
-151
-3% -$7.53K ﹤0.01% 1517
2017
Q4 		$240K Buy
5,162
+447
+9% +$18.8K ﹤0.01% 1491
2017
Q3 		$191K Buy
+4,715
New +$171K ﹤0.01% 1547

Other funds holding EBS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Victory Capital Management's EBS Position: Q2 2023 in Review

Victory Capital Management sold out of Emergent Biosolutions (EBS) in Q2 2023, closing a stake of 70,837 shares — an estimated $734K sold.

Victory Capital Management first reported a position in EBS in Q3 2017 and held it in 19 quarters. The position peaked at $4.19M in Q1 2021. 183 funds tracked by Wall St. Rank hold EBS as of Q2 2023.

  • Victory Capital Management reported no remaining Emergent Biosolutions position as of Q2 2023 after selling out during the quarter.
  • Victory Capital Management sold 70,837 Emergent Biosolutions shares in Q2 2023, an estimated $734K.
  • Victory Capital Management first reported a position in Emergent Biosolutions in Q3 2017 and held it in 19 quarters.
  • Victory Capital Management's Emergent Biosolutions position peaked at $4.19M in Q1 2021.
  • 183 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q2 2023.

Based on Victory Capital Management's 13F filing for Q2 2023, filed 27 Jul 2023.